Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2016 16:05 ET | Source: Cempra, Inc.

Cempra Appoints Dr. David Zaccardelli to Board of Directors

CHAPEL HILL, N.C., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
August 01, 2016 16:05 ET | Source: Cempra, Inc.

Cempra Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Current cash balance now expected to fund operations through 2017 Management to host webcast and conference call today at 4:30 p.m. EDTCHAPEL HILL, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- ...
August 01, 2016 07:30 ET | Source: Cempra, Inc.

Cempra Appoints John Bluth Executive Vice President, Investor Relations and Corporate Communications

CHAPEL HILL, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 25, 2016 07:30 ET | Source: Cempra, Inc.

Cempra to Report Second Quarter 2016 Financial Results

CHAPEL HILL, N.C., July 25, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 05, 2016 07:00 ET | Source: Cempra, Inc.

Cempra Announces FDA Acceptance of Solithera™ New Drug Applications in the Treatment of Community-Acquired Bacterial Pneumonia

CHAPEL HILL, N.C., July 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 28, 2016 07:00 ET | Source: Cempra, Inc.

Cempra Submits Marketing Authorization Application to EMA for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia

CHAPEL HILL, N.C., June 28, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 16, 2016 07:30 ET | Source: Cempra, Inc.

Cempra to Host Analyst and Investor Day on June 23, 2016

CHAPEL HILL, N.C., June 16, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 10, 2016 07:30 ET | Source: Cempra, Inc.

Cempra Announces Solithromycin Presentations at ASM Microbe 2016 Conference

CHAPEL HILL, N.C., June 10, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 02, 2016 08:00 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at the Jefferies 2016 Healthcare Conference

CHAPEL HILL, N.C., June 02, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 25, 2016 16:30 ET | Source: Melinta Therapeutics, Inc.

Cempra Announces Successful Results in the Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted by Japanese Partner, Toyama Chemical (a subsidiary of FUJIFILM Holdings Corporation)

Solithromycin safety and efficacy further validated by Toyama (FUJIFILM) All efficacy outcome measures favored solithromycin Management to host Q&A webcast and conference call tomorrow at 8:00...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right